These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6981349)

  • 21. A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger.
    Zumberg MS; del Rosario ML; Nejame CF; Pollock BH; Garzarella L; Kao KJ; Lottenberg R; Wingard JR
    Biol Blood Marrow Transplant; 2002; 8(10):569-76. PubMed ID: 12434952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between platelet count and bleeding risk in thrombocytopenic patients.
    Slichter SJ
    Transfus Med Rev; 2004 Jul; 18(3):153-67. PubMed ID: 15248165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of platelets in transfusion medicine.
    Brubaker DB
    J Am Osteopath Assoc; 1989 Dec; 89(12):1553-9. PubMed ID: 2621122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet function abnormalities in acute leukaemia.
    Ramos OF; Morón EC; De Castro Arenas R
    Haematologia (Budap); 1981 Dec; 14(4):383-91. PubMed ID: 6954126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
    Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-transfusion increment of platelet count in thrombocytopenic patients treated with platelet concentrates.
    Hoque MM; Rahman M; Rahman SM; Habibullah MM; Faruki MA; Rahman KH; Mamun AA; Hossain MA
    Mymensingh Med J; 2013 Jan; 22(1):64-8. PubMed ID: 23416811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Indication for platelet transfusion in patients with haematological diseases: less is more].
    Wandt H
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1877-9. PubMed ID: 20842610
    [No Abstract]   [Full Text] [Related]  

  • 28. Platelet transfusion therapy in thrombocytopaenia of haematologic malignancies.
    Charak BS; Rao K; Parikh PM; Rawat RS; Nair CN; Advani SH
    J Assoc Physicians India; 1989 Mar; 37(3):201-3. PubMed ID: 2768161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
    Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G;
    Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
    Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL.
    Navarro JT; Hernández JA; Ribera JM; Sancho JM; Oriol A; Pujol M; Millá F; Feliu E
    Haematologica; 1998 Nov; 83(11):998-1000. PubMed ID: 9864920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of platelet transfusion in children with bleeding in dengue fever.
    Pothapregada S; Kamalakannan B; Thulasingam M
    J Vector Borne Dis; 2015 Dec; 52(4):304-8. PubMed ID: 26714510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lowering the prophylactic platelet transfusion threshold: a prospective analysis.
    Lawrence JB; Yomtovian RA; Hammons T; Masarik SR; Chongkolwatana V; Creger RJ; Manka A; Lazarus HM
    Leuk Lymphoma; 2001 Mar; 41(1-2):67-76. PubMed ID: 11342358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E; Vijatov G
    Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
    Slichter SJ
    J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia.
    Vinholt PJ; Alnor A; Nybo M; Hvas AM
    Platelets; 2016 Sep; 27(6):547-54. PubMed ID: 27025360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.
    Benson K; Fields K; Hiemenz J; Zorsky P; Ballester O; Perkins J; Elfenbein G
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):102-9. PubMed ID: 8211211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic platelet transfusion in acute leukemia: which threshold should be used.
    Finazzi G
    Haematologica; 1998 Nov; 83(11):961-2. PubMed ID: 9864912
    [No Abstract]   [Full Text] [Related]  

  • 39. [Thrombocyte substitution in hematologic patients].
    Wiesneth M
    Beitr Infusionsther; 1993; 31():86-91. PubMed ID: 7693270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical aspects of thrombocyte transfusion].
    Kummer H
    Beitr Infusionther Klin Ernahr; 1986; 15():156-64. PubMed ID: 3753407
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.